Al-Sawaf, O.; Kluth, S.; Bahlo, J.; Hopfinger, G.; Fink, A. M.; Cramer, P.; Maurer, C.; Bergmann, M.; Dreyling, M.; Lange, E.; Kneba, M.; Stilgenbauer, S.; Kiehl, M. G.; Jäger, U.; Wendtner, C. M.; Fischer, K.; Hallek, M. and Eichhorst, B.
(2016):
Impact of gender on outcome after chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) or bendamustin plus R (BR) in CLL patients: a pooled analysis of the German CLL Study Group (GCLLSG).
In: Oncology Research and Treatment, Vol. 39: pp. 212-213
DOI: 10.1159/000449050
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 2296-5270 |
| Language: | English |
| Item ID: | 46634 |
| Date Deposited: | 27. Apr 2018, 08:11 |
| Last Modified: | 04. Nov 2020, 13:23 |
Actions (login required)
- View Item
